NO953067L - Expression of protective antigens - Google Patents

Expression of protective antigens

Info

Publication number
NO953067L
NO953067L NO953067A NO953067A NO953067L NO 953067 L NO953067 L NO 953067L NO 953067 A NO953067 A NO 953067A NO 953067 A NO953067 A NO 953067A NO 953067 L NO953067 L NO 953067L
Authority
NO
Norway
Prior art keywords
fragment
antigen
enzyme
expression
integration
Prior art date
Application number
NO953067A
Other languages
Norwegian (no)
Other versions
NO953067D0 (en
Inventor
Edward Albert Munn
Margaret Graham
Trevor Stanley Smith
Timothy Peter Rolph
Susan Elisabeth Newton
Original Assignee
Mallinckrodt Veterinary Inc
Biotech & Biolog Scien Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc, Biotech & Biolog Scien Res filed Critical Mallinckrodt Veterinary Inc
Publication of NO953067D0 publication Critical patent/NO953067D0/en
Publication of NO953067L publication Critical patent/NO953067L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Denne oppfinnelse tilveiebringer en fremgangsmåte for ekspresjon av et enzymantigen som i naturen er et parasitt- tarmmembranbundet eller et fragment derav som har lignende enzym- og/eller antigen-aktivitet, hvori pattedyrvertsceller blir transfektert med en vektor tilpasset til å uttrykke nevnte enzymantigen eller fragment derav, karakterisert ved at vertscellene før transformasjon er i alt vesentlig fri for endogene enzymer som har (a) den samme funksjon og (b) den samme cellemembranintegrasjon eller mangel på integrasjon, som nevnte parasittenzymantigen eller fragment derav. En slik fremgangsmåte er særlig anvendelig for ekspresjon av integrale membranaminopeptidaseantigener fra innvollsormer.This invention provides a method for expressing an enzyme antigen which is by nature a parasitic intestinal membrane bound or a fragment thereof having similar enzyme and / or antigen activity, wherein mammalian host cells are transfected with a vector adapted to express said enzyme antigen or fragment thereof. , characterized in that the host cells prior to transformation are substantially free of endogenous enzymes having (a) the same function and (b) the same cell membrane integration or lack of integration, as said parasite enzyme antigen or fragment thereof. Such a method is particularly useful for expression of integral membrane aminopeptidase antigens from intestinal worms.

NO953067A 1993-02-05 1995-08-04 Expression of protective antigens NO953067L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939302302A GB9302302D0 (en) 1993-02-05 1993-02-05 Process
PCT/GB1994/000204 WO1994018320A1 (en) 1993-02-05 1994-02-04 Expression of protective antigens

Publications (2)

Publication Number Publication Date
NO953067D0 NO953067D0 (en) 1995-08-04
NO953067L true NO953067L (en) 1995-10-04

Family

ID=10729928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953067A NO953067L (en) 1993-02-05 1995-08-04 Expression of protective antigens

Country Status (17)

Country Link
EP (1) EP0682702A1 (en)
JP (1) JPH08506726A (en)
AU (1) AU682488B2 (en)
BG (1) BG61574B1 (en)
BR (1) BR9406442A (en)
CA (1) CA2155120A1 (en)
CZ (1) CZ285042B6 (en)
FI (1) FI953682A (en)
GB (1) GB9302302D0 (en)
HU (1) HU219539B (en)
NO (1) NO953067L (en)
NZ (1) NZ261144A (en)
PL (1) PL178330B1 (en)
RU (1) RU2126045C1 (en)
UA (1) UA32437C2 (en)
WO (1) WO1994018320A1 (en)
ZA (1) ZA94740B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9209993D0 (en) * 1992-05-08 1992-06-24 Munn Edward A Vaccines
GB9322702D0 (en) 1993-11-03 1993-12-22 Agricultural & Food Res Vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8619293D0 (en) * 1986-08-07 1986-09-17 Munn E A Anthelmintic agents
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
JP2700088B2 (en) * 1991-07-25 1998-01-19 房則 濱島 Immunosuppressants
GB9209993D0 (en) * 1992-05-08 1992-06-24 Munn Edward A Vaccines
GB9322702D0 (en) * 1993-11-03 1993-12-22 Agricultural & Food Res Vaccines

Also Published As

Publication number Publication date
JPH08506726A (en) 1996-07-23
WO1994018320A1 (en) 1994-08-18
NO953067D0 (en) 1995-08-04
RU2126045C1 (en) 1999-02-10
UA32437C2 (en) 2000-12-15
FI953682A0 (en) 1995-08-02
GB9302302D0 (en) 1993-03-24
NZ261144A (en) 1998-02-26
HUT72990A (en) 1996-06-28
HU9502311D0 (en) 1995-10-30
EP0682702A1 (en) 1995-11-22
CA2155120A1 (en) 1994-08-18
HU219539B (en) 2001-05-28
AU682488B2 (en) 1997-10-09
BG99887A (en) 1996-12-31
AU5975394A (en) 1994-08-29
BG61574B1 (en) 1997-12-30
PL310109A1 (en) 1995-11-27
PL178330B1 (en) 2000-04-28
FI953682A (en) 1995-08-02
CZ285042B6 (en) 1999-05-12
CZ199495A3 (en) 1996-02-14
BR9406442A (en) 1996-02-27
ZA94740B (en) 1994-09-09

Similar Documents

Publication Publication Date Title
Hehemann et al. Bacteria of the human gut microbiome catabolize red seaweed glycans with carbohydrate-active enzyme updates from extrinsic microbes
Acosta-Serrano et al. The surface coat of procyclic Trypanosoma brucei: programmed expression and proteolytic cleavage of procyclin in the tsetse fly
Venugopal et al. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD (P) H: quinone oxidoreductase1 gene
Vignols et al. A yeast two-hybrid knockout strain to explore thioredoxin-interacting proteins in vivo
MX9606476A (en) The cytoplasmic inhibition of gene expression.
NO20050935L (en) BMP-2 estrogen responsive element and methods for using the same
Cheng et al. The 2B domain of the Escherichia coli Rep protein is not required for DNA helicase activity
GB9703406D0 (en) Expression of heterologous proteins
SG141233A1 (en) Control of gene expression
DE69534227D1 (en) SUBSTANCES AND METHODS FOR CONTROLLING THE HYPERACOUS EXTRACTION OF HUMAN TRANSPLANTS
Pontoppidan et al. Purification and characterization of myrosinase from the cabbage aphid (Brevicoryne brassicae), a brassica herbivore
EA200501772A1 (en) METHODS OF MEASURING THE EXPRESSION OF GENES FROM FIXED AND PARULIN FABRIC SAMPLE
Mourão et al. Role of the endogenous antioxidant system in the protection of Schistosoma mansoni primary sporocysts against exogenous oxidative stress
Isaac et al. Insect angiotensin‐converting enzyme: a processing enzyme with broad substrate specificity and a role in reproduction
Adamson et al. Transcriptional activation of antioxidants may compensate for selenoprotein deficiencies in A mblyomma maculatum (A cari: I xodidae) injected with selK‐or selM‐dsRNA
EP1135482A4 (en) Cancer cell vaccine
Li et al. Comparative analysis of iTRAQ-based proteome profiles of Schistosoma japonicum female worms coming from single-sex infections and bisexual infections
NO953067L (en) Expression of protective antigens
Liu et al. Generation of Plasmodium yoelii malaria parasite for conditional degradation of proteins
David et al. Isoaspartate in ribosomal protein S11 of Escherichia coli
DK0751780T3 (en) Methods for Isolating CD1-Displayed Antigens, Vaccines comprising CD1-Displayed Antigens, and Cell Lines for Use in Said Methods
Wright et al. Cell-type control of membrane biogenesis induced by HMG-CoA reductase.
Isawa et al. Construction of an infectious cDNA clone of Culex flavivirus, an insect-specific flavivirus from Culex mosquitoes
GB9720693D0 (en) Assay
AU2003239894A1 (en) Methods and constructs for high yield expression of clostripain

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application